July 2018. No Association Between Screening for Hepatocellular Carcinoma and Reduced Cancer-related Mortality in Patients with Cirrhosis. Moon AM, Weiss NS, Beste LA, Su F, Ho SB, Jin GY, Lowy E, Berry K, Ioannou GN. Gastroenterology. 2018 Jul 5. pii: S0016-5085(18)34721-8. doi: 10.1053/j.gastro.2018.06.079. [Epub ahead of print]
June 2017. Reply to: Race or Genetic Makeup for HCV Treatment Decisions? Su F, Ioannou GN. Hepatology. 2017 Jun;65(6):2125-2126. doi: 10.1002/hep.29058. Epub 2017 Apr 24.
June 2017. Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients. Su F, Beste LA, Green PK, Berry K, Ioannou GN. Eur J Gastroenterol Hepatol. 2017 Jun;29(6):686-693. doi: 10.1097/MEG.0000000000000858.
February 2017. The association between race/ethnicity and the effectiveness of direct antiviral agents for hepatitis C virus infection. Su F, Green PK, Berry K, Ioannou GN. Hepatology. 2017 Feb;65(2):426-438. doi: 10.1002/hep.28901. Epub 2016 Dec 24.
December 2016. Alcohol use and hepatitis C virus treatment outcomes among patients receiving direct antiviral agents. Tsui JI, Williams EC, Green PK, Berry K, Su F, Ioannou GN. Drug Alcohol Depend. 2016 Dec 1;169:101-109. doi: 10.1016/j.drugalcdep.2016.10.021. Epub 2016 Oct 22.
February 2016. Aging of liver transplant registrants and recipients: trends and impact on waitlist outcomes, post-transplantation outcomes and transplant-related survival benefit. Su F, Yu L, Berry K, Liou IW, Landis CS, Rayhill SC, Reyes JD, Ioannou GN. Gastroenterology. 2016 Feb;150(2):441-453.e6. doi: 10.1053/j.gastro.2015.10.043. Epub 2015 Oct 30.